Regulation of Neurotoxin Production and Sporulation by a Putative agrBD Signaling System in Proteolytic Clostridium botulinum
暂无分享,去创建一个
Nigel P. Minton | Michael W. Peck | Klaus Winzer | K. Winzer | M. Peck | W. Chan | N. Minton | C. Cooksley | Weng C. Chan | Clare M. Cooksley | Ian J. Davis | I. Davis
[1] J. Heap,et al. The ClosTron: a universal gene knock-out system for the genus Clostridium. , 2007, Journal of microbiological methods.
[2] M. Peck. Biology and genomic analysis of Clostridium botulinum. , 2009, Advances in microbial physiology.
[3] C. Tomas,et al. Overexpression of groESL in Clostridium acetobutylicum Results in Increased Solvent Production and Tolerance, Prolonged Metabolism, and Changes in the Cell's Transcriptional Program , 2003, Applied and Environmental Microbiology.
[4] N. Minton,et al. The development of Clostridium difficile genetic systems. , 2004, Anaerobe.
[5] E. Papoutsakis,et al. Metabolic flux analysis elucidates the importance of the acid-formation pathways in regulating solvent production by Clostridium acetobutylicum. , 1999, Metabolic engineering.
[6] A. T. Carter,et al. Effects of Carbon Dioxide on Growth of Proteolytic Clostridium botulinum, Its Ability To Produce Neurotoxin, and Its Transcriptome , 2009, Applied and Environmental Microbiology.
[7] M. Kleerebezem,et al. An agr-Like Two-Component Regulatory System in Lactobacillus plantarum Is Involved in Production of a Novel Cyclic Peptide and Regulation of Adherence , 2005, Journal of bacteriology.
[8] F. Vandenesch,et al. The agr P2 operon: an autocatalytic sensory transduction system in Staphylococcus aureus. , 1995, Molecular & general genetics : MGG.
[9] K. Scott,et al. Section 14 - Biotechnology and medical applications , 1995 .
[10] B. Lazazzera,et al. The extracellular Phr peptide-Rap phosphatase signaling circuit of Bacillus subtilis. , 2003, Frontiers in bioscience : a journal and virtual library.
[11] Eric A. Johnson,et al. Recombinant Holotoxoid Vaccine against Botulism , 2007, Infection and Immunity.
[12] B. McClane,et al. Use of an EZ-Tn5-Based Random Mutagenesis System to Identify a Novel Toxin Regulatory Locus in Clostridium perfringens Strain 13 , 2009, PloS one.
[13] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[14] Wei-Jen Lin,et al. Variations in expression and release of botulinum neurotoxin in Clostridium botulinum type A strains. , 2007, Foodborne pathogens and disease.
[15] E. Holst,et al. Relative Neurotoxin Gene Expression in Clostridium botulinum Type B, Determined Using Quantitative Reverse Transcription-PCR , 2004, Applied and Environmental Microbiology.
[16] S. Arvidson,et al. The role of the delta‐lysin gene (hld) in the regulation of virulence genes by the accessory gene regulator (agr) in Staphylococcus aureus. , 1990, The EMBO journal.
[17] K. Winzer,et al. Look who's talking: communication and quorum sensing in the bacterial world , 2007, Philosophical Transactions of the Royal Society B: Biological Sciences.
[18] Eric A. Johnson,et al. Regulation of neurotoxin complex expression in Clostridium botulinum strains 62A, Hall A-hyper, and NCTC 2916. , 2004, Anaerobe.
[19] Julian Parkhill,et al. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome , 2006, Nature Genetics.
[20] Eleftherios T. Papoutsakis,et al. Antisense RNA Strategies for Metabolic Engineering of Clostridium acetobutylicum , 1999, Applied and Environmental Microbiology.
[21] M. Popoff,et al. Expression of botulinum neurotoxins A and E, and associated non-toxin genes, during the transition phase and stability at high temperature: analysis by quantitative reverse transcription-PCR. , 2006, Microbiology.
[22] K. Inoue,et al. botR/A is a positive regulator of botulinum neurotoxin and associated non‐toxin protein genes in Clostridium botulinum A , 1998, Molecular microbiology.
[23] S. Elliott,et al. Botulism: the many faces of botulinum toxin and its potential for bioterrorism. , 2006, Infectious disease clinics of North America.
[24] E. Papoutsakis,et al. Design of Antisense RNA Constructs for Downregulation of the Acetone Formation Pathway of Clostridium acetobutylicum , 2003, Journal of bacteriology.
[25] A. T. Carter,et al. Genome sequence of a proteolytic (Group I) Clostridium botulinum strain Hall A and comparative analysis of the clostridial genomes. , 2007, Genome research.
[26] C. Livesey,et al. Diagnosis and implications of botulism , 2008, In Practice.
[27] P. Dürre,et al. Initiation of endospore formation in Clostridium acetobutylicum. , 2004, Anaerobe.
[28] Tohru Shimizu,et al. Virulence Gene Regulation by the agr System in Clostridium perfringens , 2009, Journal of bacteriology.
[29] M. Sarker,et al. Antisense-RNA-Mediated Decreased Synthesis of Small, Acid-Soluble Spore Proteins Leads to Decreased Resistance of Clostridium perfringens Spores to Moist Heat and UV Radiation , 2007, Applied and Environmental Microbiology.
[30] A. Charbit,et al. Identification of the agr Locus of Listeria monocytogenes: Role in Bacterial Virulence , 2003, Infection and Immunity.
[31] N. Minton,et al. Development of a transformation and gene reporter system for group II, non-proteolytic Clostridium botulinum type B strains. , 2000, Journal of molecular microbiology and biotechnology.
[32] C. Shone,et al. Monoclonal antibody-based immunoassay for type A Clostridium botulinum toxin is comparable to the mouse bioassay , 1985, Applied and environmental microbiology.
[33] S. Junne,et al. Antisense RNA Downregulation of Coenzyme A Transferase Combined with Alcohol-Aldehyde Dehydrogenase Overexpression Leads to Predominantly Alcohologenic Clostridium acetobutylicum Fermentations , 2003, Journal of bacteriology.
[34] R. Novick. Autoinduction and signal transduction in the regulation of staphylococcal virulence , 2003, Molecular microbiology.
[35] J. M. Dow,et al. A two‐component system involving an HD‐GYP domain protein links cell–cell signalling to pathogenicity gene expression in Xanthomonas campestris , 2000, Molecular microbiology.
[36] A. McLeod,et al. Conjugative transfer of clostridial shuttle vectors from Escherichia coli to Clostridium difficile through circumvention of the restriction barrier , 2002, Molecular microbiology.
[37] A. T. Carter,et al. Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum , 2009, BMC Genomics.
[38] E J Schantz,et al. Properties and use of botulinum toxin and other microbial neurotoxins in medicine. , 1992, Microbiological reviews.